Brevia Health has been delivering Political Due Diligence support to investors for over 20 years. Our work started in 1999 during the dot-com boom supporting venture capital companies investing in new, digital start-ups. Since then, we have supported private equity investors and corporate clients in making acquisition and exit decisions.
At a time of heightened political uncertainty, our team of experienced consultants can provide clear analysis of political, policy and regulatory risks. Our advisory board members who have been involved in making transactions, recognise at first-hand the value that Political Due Diligence can play in identifying political & regulatory risks and opportunities. The support our team can offer extends beyond deal completion and includes post-deal communications support and risk mitigation activity.
Brevia Health is a public affairs, public relations and market access consultancy that can support investors with a full range of services from political and media monitoring, to comprehensive stakeholder engagement programmes. The latter service is of particular value if the political due diligence identifies the need for the investor to engage with political & regulatory stakeholders in the event of a policy or regulatory hurdle.
